No profile data available.
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. (GEDSF) is a healthcare company in the multi-therapeutic drug manufacturing industry, based in Budapest, Hungary, with about 11,155 full-time employees.
It reported revenue of 928.96 billion HUF for fiscal year 2025, up 8.3% from fiscal year 2024, and net income of 232.34 billion HUF. Its market capitalization was $4.53 billion as of October 8, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 8, 2026.
Gedeon Richter PLC researches, develops, manufactures, markets, and sells pharmaceutical products. It offers women's healthcare products for contraceptives, endometriosis, fertility, menopause, vaginal infections, and uterine fibroids; and Femtech, a digital therapeutic solution to enhance women's lives.
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. reported 928.96 billion HUF in revenue for fiscal year 2025, up 8.3% from 857.55 billion HUF in fiscal year 2024.
$4.53 billion as of October 8, 2026.
Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include Ligand Pharmaceuticals Incorporated (LGND), Crispr Therapeutics AG (CRSP), Grifols, S.a. (GRFS), Aspen Pharmacare Holdings Limited (APNHY).